A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo	Skin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligo	Recruiting	Phase 2	2026-09-09		NCT07431177

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Novartis Pharmaceuticals	432

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
ACRC Trials	Plano	United States	4
Austin Inst for Clinical Research	Pflugerville	United States	4
Bellaire Dermatology Associates	Bellaire	United States	4
Cahaba Derm and skin hlth ctr 27	Birmingham	United States	4
Center for Clinical Studies	Houston	United States	2
Clinical Trials Research Institute	Thousand Oaks	United States	5
Dawes Fretzin Clinical Rea Group	Indianapolis	United States	6
Encore Medical Research	Hollywood	United States	15
Equity Medical	The Bronx	United States	6
First Oc Dermatology	Fountain Valley	United States	16
Global Clinical Professionals	St. Petersburg	United States	4
Hamzavi Dermatology	Fort Gratiot	United States	7
International Clinical Research Tennessee LCC	Murfreesboro	United States	2
Las Vegas Dermatology	Las Vegas	United States	4
Mayo Clinic Jacksonville	Jacksonville	United States	67
MedDerm Associates	San Diego	United States	3
Miami Derm and Laser Institute	Miami	United States	2
Oregon Medical Research Center	Portland	United States	2
Revival Research Institute	Troy	United States	4
Skin Specialists PC	Omaha	United States	7
Virginia Clinical Research	Norfolk	United States	2

Clinical trials